Open Access. Powered by Scholars. Published by Universities.®
- Discipline
-
- Medical Specialties (60)
- Cardiology (53)
- Analytical, Diagnostic and Therapeutic Techniques and Equipment (10)
- Therapeutics (7)
- Public Health (6)
-
- Surgical Procedures, Operative (6)
- Health Services Research (5)
- Nervous System Diseases (4)
- Diagnosis (3)
- Health and Medical Administration (3)
- Neurosurgery (3)
- Pediatrics (3)
- Other Analytical, Diagnostic and Therapeutic Techniques and Equipment (2)
- Pathological Conditions, Signs and Symptoms (2)
- Surgery (2)
- Biological Factors (1)
- Chemicals and Drugs (1)
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)
- Emergency Medicine (1)
- Geriatrics (1)
- Health Services Administration (1)
- Investigative Techniques (1)
- Lipids (1)
- Medical Sciences (1)
- Neurology (1)
- Patient Safety (1)
- Radiology (1)
- Institution
- Publication Year
- Publication
- Publication Type
Articles 61 - 62 of 62
Full-Text Articles in Cardiovascular Diseases
Left Atrial Ablation For Atrial Fibrillation: Creating The “Box Lesion” With A Bipolar Radiofrequency Device, Leonid Sternik, Hartzel V Schaff, David Luria, Michael Glikson, Alexander Kogan, Ateret Malachy, Maya First, Ehud Raanani
Left Atrial Ablation For Atrial Fibrillation: Creating The “Box Lesion” With A Bipolar Radiofrequency Device, Leonid Sternik, Hartzel V Schaff, David Luria, Michael Glikson, Alexander Kogan, Ateret Malachy, Maya First, Ehud Raanani
The Texas Heart Institute Journal
The maze procedure is the gold standard for the ablation of atrial fibrillation, and the “box lesion” around the pulmonary veins is the most important part of this procedure. We have created this lesion with a bipolar radiofrequency ablator, abandoning the usual use of this device (to achieve bilateral epicardial isolation of the pulmonary veins).
From March 2004 through the end of May 2010, we performed surgical ablation of atrial fibrillation in 240 patients. Of this number, 205 underwent operation by a hybrid maze technique and the remaining 35 (our study cohort) underwent the creation of a box lesion around …
Rhoa/Rho-Kinase Signaling: A Therapeutic Target In Pulmonary Hypertension, Scott A. Barman, Shu Zhu, Richard E. White
Rhoa/Rho-Kinase Signaling: A Therapeutic Target In Pulmonary Hypertension, Scott A. Barman, Shu Zhu, Richard E. White
PCOM Scholarly Works
Pulmonary arterial hypertension (PAH) is a devastating disease characterized by progressive elevation of pulmonary arterial pressure and vascular resistance due to pulmonary vasoconstriction and vessel remodeling as well as inflammation. Rho-kinases (ROCKs) are one of the best-described effectors of the small G-protein RhoA, and ROCKs are involved in a variety of cellular functions including muscle cell contraction, proliferation and vascular inflammation through inhibition of myosin light chain phosphatase and activation of downstream mediators. A plethora of evidence in animal models suggests that heightened RhoA/ROCK signaling is important in the pathogenesis of pulmonary hypertension by causing enhanced constriction and remodeling of …